The University of Chicago Header Logo

Connection

Dezheng Huo to Azacitidine

Back to Details
This is a "connection" page, showing publications Dezheng Huo has written about Azacitidine.
Dezheng Huo
Connection Strength
0.249
Azacitidine
  1. A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis. Blood Adv. 2024 Nov 26; 8(22):5735-5743.
    View in: PubMed
    Score: 0.229
  2. CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors. Breast Cancer Res Treat. 2010 Apr; 120(3):593-601.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.